functional abdominal pain in the context of irritable bowel syndrome ibs is a challenging problem for primary care physicians gastroenterologists and pain specialistswe review the evidence for the current and future nonpharmacological and pharmacological treatment options targeting the central nervous system and the gastrointestinal tractcognitive interventions such as cognitive behavioral therapy and hypnotherapy have demonstrated excellent results in ibs patients but the limited availability and laborintensive nature limit their routine use in daily practicein patients who are refractory to firstline therapy tricyclic antidepressants tca and selective serotonin reuptake inhibitors are both effective to obtain symptomatic relief but only tcas have been shown to improve abdominal pain in metaanalysesa diet low in fermentable carbohydrates and polyols fodmap seems effective in subgroups of patients to reduce abdominal pain bloating and to improve the stool patternthe evidence for fiber is limited and only isphagula may be somewhat beneficialthe efficacy of probiotics is difficult to interpret since several strains in different quantities have been used across studiesantispasmodics including peppermint oil are still considered the firstline treatment for abdominal pain in ibssecondline therapies for diarrheapredominant ibs include the nonabsorbable antibiotic rifaximin and the 5ht3 antagonists alosetron and ramosetron although the use of the former is restricted because of the rare risk of ischemic colitisin laxativeresistant constipationpredominant ibs the chloridesecretion stimulating drugs lubiprostone and linaclotide a guanylate cyclase c agonist that also has direct analgesic effects reduce abdominal pain and improve the stool pattern